764 related articles for article (PubMed ID: 8632274)
21. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN
Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459
[TBL] [Abstract][Full Text] [Related]
23. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.
Leboulleux S; Travagli JP; Caillou B; Laplanche A; Bidart JM; Schlumberger M; Baudin E
Cancer; 2002 Jan; 94(1):44-50. PubMed ID: 11815959
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma: state of the art.
Favia G; Iacobone M
G Chir; 2005; 26(11-12):405-9. PubMed ID: 16472416
[TBL] [Abstract][Full Text] [Related]
25. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A.
Puñales MK; da Rocha AP; Meotti C; Gross JL; Maia AL
Thyroid; 2008 Dec; 18(12):1261-8. PubMed ID: 18991485
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2.
Prete FP; Abdel-Aziz T; Morkane C; Brain C; Kurzawinski TR;
Br J Surg; 2018 Sep; 105(10):1319-1327. PubMed ID: 29663329
[TBL] [Abstract][Full Text] [Related]
27. Medullary thyroid carcinoma in Northern Ireland, 1967-1997.
Dolan SJ; Russell CF
Ann R Coll Surg Engl; 2000 May; 82(3):156-61. PubMed ID: 10858675
[TBL] [Abstract][Full Text] [Related]
28. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Takami H
Endocr Pathol; 2003; 14(2):123-31. PubMed ID: 12858002
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome.
Lallier M; St-Vil D; Giroux M; Huot C; Gaboury L; Oligny L; Desjardins JG
J Pediatr Surg; 1998 Jun; 33(6):846-8. PubMed ID: 9660211
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.
Febrero B; Rodríguez JM; Ríos A; Segura P; Pérez-Sánchez B; Torregrosa N; Hernández AM; Parrilla P
Eur J Surg Oncol; 2019 Apr; 45(4):625-630. PubMed ID: 30366876
[TBL] [Abstract][Full Text] [Related]
31. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated?
Decker RA; Geiger JD; Cox CE; Mackovjak M; Sarkar M; Peacock ML
World J Surg; 1996 Sep; 20(7):814-20; discussion 820-1. PubMed ID: 8678956
[TBL] [Abstract][Full Text] [Related]
33. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
Quayle FJ; Moley JF
J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378
[TBL] [Abstract][Full Text] [Related]
34. Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
Frilling A; Dralle H; Eng C; Raue F; Broelsch CE
Surgery; 1995 Dec; 118(6):1099-103; discussion 1103-4. PubMed ID: 7491529
[TBL] [Abstract][Full Text] [Related]
35. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
[TBL] [Abstract][Full Text] [Related]
36. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
37. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
[TBL] [Abstract][Full Text] [Related]
38. [Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
Murat A; Modigliani E; Conte-Devolx B; Rohmer V; Leclerc L; Guilhem I; Bigorgne JC; Boneu A; Maes B; Chabre O; Niccoli P; Schuffenecker I; Giraud S
Ann Chir; 1998; 52(5):455-60. PubMed ID: 9752487
[TBL] [Abstract][Full Text] [Related]
39. Multiple endocrine neoplasia type 2A: a 25-year review.
Iler MA; King DR; Ginn-Pease ME; O'Dorisio TM; Sotos JF
J Pediatr Surg; 1999 Jan; 34(1):92-6; discussion 96-7. PubMed ID: 10022151
[TBL] [Abstract][Full Text] [Related]
40. Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.
Szinnai G; Meier C; Komminoth P; Zumsteg UW
Pediatrics; 2003 Feb; 111(2):E132-9. PubMed ID: 12563086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]